NuroKor Overview
- Year Founded
-
2018
- Status
-
Out of Business
- Employees
-
11
- Latest Deal Type
-
Out of Business
NuroKor General Information
Description
Developer of bioelectronic ultra-wearable personal medical devices designed to improve health and well-being through non-invasive technology. The company uses the understanding of neurophysiology and molecular mechanisms, guiding the design of devices that work in natural harmony with the body system, and technology uses the power of bio current with bioelectrical medicine, with a new wave of wearable technologies, enabling the healthcare industry to avail complete body therapy system and manage pain.
Contact Information
Website
www.nurokor.comCorporate Office
- 128 City Road
- London EC1V 2NX
- England, United Kingdom
Corporate Office
- 128 City Road
- London EC1V 2NX
- England, United Kingdom
NuroKor Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Out of Business | 12-Apr-2026 | Completed | Out of Business | |||
| 5. Accelerator/Incubator | 16-Mar-2023 | Completed | Generating Revenue | |||
| 4. Equity Crowdfunding | 27-Apr-2022 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 03-Mar-2021 | $2.78M | $2.78M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 01-Jan-2021 | $805K | Cancelled | Generating Revenue |
NuroKor Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 218,750 | $0.000001 | $0.73 | $0.73 | 1x | $0.73 | 1.42% | |
| Ordinary | 276,250 | $0.000001 | $1.11 | $1.11 | 1x | $1.11 | 1.79% |
NuroKor Comparisons
Industry
Financing
Details
NuroKor Competitors (6)
One of NuroKor’s 6 competitors is Sky Medical Technology, a Venture Capital-Backed company based in High Wycombe, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sky Medical Technology | Venture Capital-Backed | High Wycombe, United Kingdom | ||||
| Galvani Bioelectronics | Corporate Backed or Acquired | Stevenage, United Kingdom | ||||
| Elvie | Formerly VC-backed | London, United Kingdom | ||||
| Ceryx Medical | Venture Capital-Backed | Cardiff, United Kingdom | ||||
| QV Bioelectronics | Venture Capital-Backed | Macclesfield, United Kingdom |
NuroKor Patents
NuroKor Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202018911-D0 | A bioelectrical stimulation system | Inactive | 01-Dec-2020 | ||
| GB-2589738-A | A bioelectrical stimulation system | Inactive | 01-Dec-2020 | ||
| WO-2022118001-A1 | A bioelectrical stimulation system | Inactive | 01-Dec-2020 | A61N1/3603 |
NuroKor Signals
NuroKor FAQs
-
When was NuroKor founded?
NuroKor was founded in 2018.
-
Where is NuroKor headquartered?
NuroKor is headquartered in London, United Kingdom.
-
What is the size of NuroKor?
NuroKor has 11 total employees.
-
What industry is NuroKor in?
NuroKor’s primary industry is Therapeutic Devices.
-
Is NuroKor a private or public company?
NuroKor is a Private company.
-
What is NuroKor’s current revenue?
The current revenue for NuroKor is .
-
How much funding has NuroKor raised over time?
NuroKor has raised $3.59M.
-
Who are NuroKor’s competitors?
Sky Medical Technology, Galvani Bioelectronics, Elvie, Ceryx Medical, and QV Bioelectronics are some of the 6 competitors of NuroKor.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process